@article{fe0643f20815423eb0f1b81e91df22e1,
title = "On the road to ending the COVID-19 pandemic: Are we there yet?",
abstract = "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged into the human population in late 2019 and caused the global COVID-19 pandemic. SARS-CoV-2 has spread to more than 215 countries and infected many millions of people. Despite the introduction of numerous governmental and public health measures to control disease spread, infections continue at an unabated pace, suggesting that effective vaccines and antiviral drugs will be required to curtail disease, end the pandemic, and restore societal norms. Here, we review the current developments in antibody and vaccine countermeasures to limit or prevent disease.",
keywords = "Antibody, COVID-19, Immunity, Pathogenesis, Protection, SARS-CoV-2, Therapy, Vaccines",
author = "Case, {James Brett} and Winkler, {Emma S.} and Errico, {John M.} and Diamond, {Michael S.}",
note = "Funding Information: This work was supported by R01 AI157155 and the Defense Advanced Research Project Agency ( HR001117S0019 ). J.B.C. is supported by a Helen Hay Whitney Foundation postdoctoral fellowship. E.S.W. is supported by F30 AI152327-01 . We thank Daved Fremont for critical comments on the manuscript. We apologize to our colleagues for omissions due to space constraints or the fluid nature of advances. An up-to-date list of SARS-CoV-2 vaccines and therapeutic mAbs can be found at https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines and https://www.antibodysociety.org/covid-19-biologics-tracker/ . Publisher Copyright: {\textcopyright} 2021 Elsevier Inc.",
year = "2021",
month = may,
doi = "10.1016/j.virol.2021.02.003",
language = "English",
volume = "557",
pages = "70--85",
journal = "Virology",
issn = "0042-6822",
}